While in the MCF-10AHER2 tumor progression model, which exhibits Doxorubicin-induced HER-2 overexpression and is cultured in Matrigel®, malignant transformation was shown to trigger the activation of tyrosine kinases that subsequently activate FAK. Here, ERBB2 is linked to neoplasm.